Machine learning with magnetic resonance imaging for prediction of response to neoadjuvant chemotherapy in breast cancer: A systematic review and meta-analysis

被引:30
|
作者
Liang, Xueheng [1 ]
Yu, Xingyan [2 ]
Gao, Tianhu [1 ]
机构
[1] Peoples Hosp Chongqing Banan Dist, Dept Radiol, Chongqing, Peoples R China
[2] Chongqing Med Univ, Affiliated Hosp 1, Dept Nucl Med, Chongqing, Peoples R China
关键词
Breast neoplasms; Machine learning; Magnetic resonance imaging; Neoadjuvant therapy; ACCURACY; MRI;
D O I
10.1016/j.ejrad.2022.110247
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: The aim of this meta-analysis was to determine the diagnostic accuracy of machine learning (ML) models with MRI in predicting pathological response to neoadjuvant chemotherapy in patients with breast cancer. Furthermore, we compared the pathologic complete response (pCR) prediction performance of ML + radiomics with that of a deep learning (DL) algorithm. Methods: A search for relevant studies published until December 20, 2021 was conducted in MEDLINE and EMBASE databases. The quality of the studies was assessed using the Quality Assessment of Diagnostic Accuracy Studies -2 criteria. The I-2 value assessed the heterogeneity of the included studies as well as the decision to adopt a random effects model. The area under the receiver operating characteristic curves (AUC) was pooled to quantify the predictive accuracy. Subgroup analysis, meta-regression analysis, and sensitivity analysis were performed to detect potential sources of study heterogeneity. A funnel plot was used to investigate publication bias. The PROSPERO ID of our study was CRD42022284071. Result: Seventeen eligible studies encompassing 3392 patients were evaluated in the analysis. ML + MRI showed high accuracy (AUC = 0.87, 95% CI = 0.84-0.91) in predicting response to neoadjuvant therapy. In subgroup analysis, the AUC of the DL subgroup (AUC = 0.92, 95% CI = 0.88-0.97) was higher than that of the ML + radiomics subgroup (AUC = 0.85, 95% CI = 0.82-0.90) (P = 0.030). In the ML + radiomics subgroup, the studies using MRI combined with other parameters (clinical or histopathologic information; AUC = 0.90, 95% CI = 0.85-0.96) reported better performance than studies using only MRI parameters (AUC = 0.82, 95% CI = 0.78-0.86) (P = 0.009). Conclusions: ML applied to MRI enabled moderate accuracy in predicting pathological response to neoadjuvant therapy in patients with breast cancer. Furthermore, the meta-analysis showed that DL had higher predictive accuracy than ML + radiomics.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Unlocking the potential of circulating miRNAs in predicting response to neoadjuvant chemotherapy in breast cancer: A systematic review and meta-analysis
    Tiberio, P.
    Gaudio, M.
    Belloni, S.
    Benvenuti, C.
    Jacobs, F.
    Saltalamacchia, G.
    Zambelli, A.
    Santoro, A.
    De Sanctis, R.
    ANNALS OF ONCOLOGY, 2023, 34 : S301 - S301
  • [22] Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer
    Fu, Juzhong
    Fan, Ming
    Zheng, Bin
    Shao, Guoliang
    Zhang, Juan
    Li, Lihua
    MEDICAL IMAGING 2016: PACS AND IMAGING INFORMATICS: NEXT GENERATION AND INNOVATIONS, 2016, 9789
  • [23] MRI and PET/CT for evaluation of the pathological response to neoadjuvant chemotherapy in breast cancer: A systematic review and meta-analysis
    Li, Huimin
    Yao, Liang
    Jin, Penghui
    Hu, Lidong
    Li, Xiaofei
    Guo, Tiankang
    Yang, Kehu
    BREAST, 2018, 40 : 106 - 115
  • [24] Impact of neoadjuvant chemotherapy on breast reconstruction - systematic review and meta-analysis
    Varghese, Jajini Susan
    Gohari, Shireen
    Shawky, Michael
    Hyun, Faith
    Johnson, Laura
    Schmid, Peter
    CANCER RESEARCH, 2021, 81 (04)
  • [25] Magnetic Resonance Imaging to predict pathological response neoadjuvant chemotherapy for breast cancer
    Lamot, C.
    Van fraeyenhove, F.
    Denys, H.
    Van Herreweghe, E.
    Van den Broecke, R.
    Villeirs, G.
    Depypere, H.
    Praet, M.
    Cocquyt, V.
    EJC SUPPLEMENTS, 2008, 6 (07): : 60 - 61
  • [26] Role of Magnetic Resonance Imaging in the Evaluation of Breast Cancer Response to Neoadjuvant Chemotherapy
    Pasquero, Giorgia
    Surace, Alessandra
    Ponti, Antonio
    Bortolini, Massimiliano
    Tota, Donatella
    Mano, Maria Piera
    Arisio, Riccardo
    Benedetto, Chiara
    Bau, Maria Grazia
    IN VIVO, 2020, 34 (02): : 909 - 915
  • [27] Dynamic Breast Magnetic Resonance Imaging: Pretreatment Prediction of Tumor Response to Neoadjuvant Chemotherapy
    He Dongfeng
    Ma Daqing
    Jin Erhu
    CLINICAL BREAST CANCER, 2012, 12 (02) : 94 - 101
  • [28] MAGNETIC RESONANCE IMAGING -RADIOMICS IN ENDOMETRIAL CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Cuccu, Ilaria
    Di Donato, Violante
    Kontopantelis, Evangelos
    D'Auge, Tullio Golia
    Perniola, Giorgia
    Palaia, Innocenza
    Tomao, Federica
    Giannini, Andrea
    Muzii, Ludovico
    Bogani, Giorgio
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 : A156 - A156
  • [29] Neoadjuvant chemotherapy regimens in treatment of breast cancer: a systematic review and network meta-analysis protocol
    Mona Pathak
    Sada Nand Dwivedi
    S. V. S. Deo
    Bhaskar Thakur
    Vishnubhatla Sreenivas
    G. K. Rath
    Systematic Reviews, 7
  • [30] Effectiveness of Added Targeted Therapies to Neoadjuvant Chemotherapy for Breast Cancer: A Systematic Review and Meta-analysis
    Pathak, Mona
    Dwivedi, Sada Nand
    Deo, S. V. S.
    Thakur, Bhaskar
    Sreenivas, Vishnubhada
    Rath, G. K.
    CLINICAL BREAST CANCER, 2019, 19 (06) : E690 - E700